Back to top Open menu arrow
The Journal of Clinical Psychiatry The Journal of Clinical Psychiatry

The Journal of
Clinical Psychiatry
Access icon

This article is available to members only. Please enjoy the abstract for free. Subscribe for instant access to the full article.

This content is restricted to subscribers

Continue Reading...

Did you know members enjoy unlimited free PDF downloads as part of their subscription? Subscribe today for instant access to this article and our entire library in your preferred format. Alternatively, you can purchase the PDF of this article individually.

Subscribe Now

Already a member? Login

Purchase PDF for $40

Members enjoy free PDF downloads on all articles. Join today

  1. Department of Psychosis Studies, Institute of Psychiatry, Psychology and Neuroscience, King’s College London, London, United Kingdom
  2. Corresponding Author: Dina Farran, Institute of Psychiatry, Psychology and Neuroscience, King’s College London, 16 De Crespigny Park, London SE5 8AB, UK ([email protected]).
  3. South London and Maudsley NHS Foundation Trust, London, United Kingdom
  4. Department of Psychosis Studies, Institute of Psychiatry, Psychology and Neuroscience, King’s College London, London, United Kingdom
  5. South London and Maudsley NHS Foundation Trust, London, United Kingdom
  6. ); School of Life Course and Population Sciences, King’s College London, London, United Kingdom
  7. Department of Psychosis Studies, Institute of Psychiatry, Psychology and Neuroscience, King’s College London, London, United Kingdom
  8. South London and Maudsley NHS Foundation Trust, London, United Kingdom
  1. Hindricks G, Potpara T, Dagres N, et al; ESC Scientific Document Group. 2020 ESC Guidelines for the diagnosis and management of atrial fibrillation developed in collaboration with the European Association for Cardio-Thoracic Surgery (EACTS): The Task Force for the diagnosis and management of atrial fibrillation of the European Society of Cardiology (ESC) Developed with the special contribution of the European Heart Rhythm Association (EHRA) of the ESC. Eur Heart J. 2021;42(5):373–498. PubMed CrossRef
  2. Hart RG, Pearce LA, Aguilar MI. Meta-analysis: antithrombotic therapy to prevent stroke in patients who have nonvalvular atrial fibrillation. Ann Intern Med. 2007;146(12):857–867. PubMed CrossRef
  3. Odum L, Cochran K, Aistrope D, et al. The CHADS2 versus the new CHA2DS2-VASc scoring systems for guiding antithrombotic treatment of patients with atrial fibrillation: review of the literature and recommendations for use. Pharmacotherapy. 2012;32(3):285–296. PubMed CrossRef
  4. Jones C, Pollit V, Fitzmaurice D, et al; Guideline Development Group. The management of atrial fibrillation: summary of updated NICE guidance. BMJ. 2014;348(jun19 1):g3655. PubMed CrossRef
  5. Højen AA, Nielsen PB, Riahi S, et al. Disparities in oral anticoagulation initiation in patients with schizophrenia and atrial fibrillation: a nationwide cohort study. Br J Clin Pharmacol. 2022;88(8):3847–3855. PubMed CrossRef
  6. Fenger-Grøn M, Vestergaard CH, Ribe AR, et al. Association between bipolar disorder or schizophrenia and oral anticoagulation use in Danish adults with incident or prevalent atrial fibrillation. JAMA Netw Open. 2021;4(5):e2110096. PubMed CrossRef
  7. Jaakkola J, Teppo K, Biancari F, et al. The effect of mental health conditions on the use of oral anticoagulation therapy in patients with atrial fibrillation: the FinACAF study. Eur Heart J Qual Care Clin Outcomes. 2022;8(3):269–276. PubMed CrossRef
  8. Fanning L, Ryan-Atwood TE, Bell JS, et al. Prevalence, safety, and effectiveness of oral anticoagulant use in people with and without dementia or cognitive impairment: a systematic review and meta-analysis. J Alzheimers Dis. 2018;65(2):489–517. PubMed CrossRef
  9. Mongkhon P, Alwafi H, Fanning L, et al. Patterns and factors influencing oral anticoagulant prescription in people with atrial fibrillation and dementia: Results from UK primary care. Br J Clin Pharmacol. 2021;87(3):1056–1068. PubMed CrossRef
  10. Levin JB, Aebi ME, Tatsuoka C, et al. Adherence to psychotropic and nonpsychotropic medication among patients with bipolar disorder and general medical conditions. Psychiatr Serv. 2016;67(3):342–345. PubMed CrossRef
  11. Blixen CE, Kanuch S, Perzynski AT, et al. Barriers to self-management of serious mental illness and diabetes. Am J Health Behav. 2016;40(2):194–204. PubMed CrossRef
  12. Ruff CT, Giugliano RP, Braunwald E, et al. Comparison of the efficacy and safety of new oral anticoagulants with warfarin in patients with atrial fibrillation: a meta-analysis of randomised trials. Lancet. 2014;383(9921):955–962. PubMed CrossRef
  13. Schauer DP, Moomaw CJ, Wess M, et al. Psychosocial risk factors for adverse outcomes in patients with nonvalvular atrial fibrillation receiving warfarin. J Gen Intern Med. 2005;20(12):1114–1119. PubMed CrossRef
  14. Lawrence D, Kisely S. Inequalities in healthcare provision for people with severe mental illness. J Psychopharmacol. 2010;24(suppl):61–68. PubMed CrossRef
  15. HONOS ASSESSMENT (Health of the Nation Outcome Scales). Peardonville House. Accessed January 18, 2023. https://peardonvillehouse.ca/wp-content/uploads/2018/12/Assessments.pdf
  16. Hayes RD, Chang CK, Fernandes AC, et al. Functional status and all-cause mortality in serious mental illness. PLoS One. 2012;7(9):e44613. PubMed CrossRef
  17. Hayes RD, Chang CK, Fernandes A, et al. Associations between symptoms and all-cause mortality in individuals with serious mental illness. J Psychosom Res. 2012;72(2):114–119. PubMed CrossRef
  18. Wu CY, Chang CK, Hayes RD, et al. Clinical risk assessment rating and all-cause mortality in secondary mental healthcare: the South London and Maudsley NHS Foundation Trust Biomedical Research Centre (SLAM BRC) Case Register. Psychol Med. 2012;42(8):1581–1590. PubMed CrossRef
  19. Su YP, Chang CK, Hayes RD, et al. Mini-mental state examination as a predictor of mortality among older people referred to secondary mental healthcare. PLoS One. 2014;9(9):e105312. PubMed CrossRef
  20. Stewart R, Soremekun M, Perera G, et al. The South London and Maudsley NHS Foundation Trust Biomedical Research Centre (SLAM BRC) case register: development and descriptive data. BMC Psychiatry. 2009;9(1):51. PubMed CrossRef
  21. CHA2DS2-VASc Score for Atrial Fibrillation Stroke Risk. MDCalc. Accessed January 18, 2023.https://www.mdcalc.com/calc/801/cha2ds2-vasc-score-atrial-fibrillation-stroke-risk
  22. ORBIT Bleeding Risk Score for Atrial Fibrillation. MDCalc. Accessed January 18, 2023.https://www.mdcalc.com/calc/10227/orbit-bleeding-risk-score-atrial-fibrillation
  23. CRIS NLP Service. Library of production-ready applications. 2021. Vol 6. https://www.maudsleybrc.nihr.ac.uk/media/463740/applications-library-v21.pdf. Accessed January 18, 2023.
  24. Kadra G, Stewart R, Shetty H, et al. Extracting antipsychotic polypharmacy data from electronic health records: developing and evaluating a novel process. BMC Psychiatry. 2015;15(1):166. PubMed CrossRef
  25. Farran D, Bean D, Wang T, et al. Anticoagulation for atrial fibrillation in people with serious mental illness in the general hospital setting. J Psychiatr Res. 2022;153:167–173. PubMed CrossRef
  26. Correll CU, Solmi M, Veronese N, et al. Prevalence, incidence and mortality from cardiovascular disease in patients with pooled and specific severe mental illness: a large-scale meta-analysis of 3,211,768 patients and 113,383,368 controls. World Psychiatry. 2017;16(2):163–180. PubMed CrossRef
  27. Roth JA, Bradley K, Thummel KE, et al. Alcohol misuse, genetics, and major bleeding among warfarin therapy patients in a community setting. Pharmacoepidemiol Drug Saf. 2015;24(6):619–627. PubMed CrossRef
Purchase PDF for $40

Members enjoy free PDF downloads on all articles. Join today

Save Save

Share Share

Cite Cite

Celebrating
85 Years

Read the Journal of Clinical Psychiatry

Subscribe to read
more articles

Subscribe now